Unidoc Health files annual financial statements

Executive Summary

• Unidoc Health Corp. has completed the filing of its annual financial statements for the fiscal year ended March 31, 2025, resolving a previous delay caused by audit timelines and an independent valuation requirement.
• The completion of these filings is expected to lead to the revocation of a Cease Trade Order (CTO) issued by the British Columbia Securities Commission on August 5, 2025, and the resumption of trading.
• The company reports successful integration of the Agnes Connect software, positive client response including contract renewals, and the shipment of Unidoc H3 Health Cubes for upcoming customer installations.

Key Details

• Financial Filings: Annual financial statements, management discussion and analysis, and certifications for the year ended March 31, 2025, are now completed.
• Regulatory Status: A Cease Trade Order (CTO) was issued by the BC Securities Commission on August 5, 2025, due to delays in the annual audit and a one-time requirement for an independent valuation of the Agnes Connect Software.
• Trading Resumption: Trading is expected to resume shortly after the filing of the financial statements and the revocation of the CTO.
• Software Integration: The Agnes Connect software and assets acquired from AMD Telemedicine have been fully integrated into Unidoc's operations.
• Sales & Partnerships: The company has observed positive client response, including renewals of expiring contracts. Unidoc has partnered with sales consultants specializing in Agnes software, including former AMD CEO Eric Bacon, to expand sales reach.
• Product Deployment: Several Unidoc H3 Health Cubes have been shipped from the factory, with customer installation announcements expected in the coming weeks.
• Market Context: The global telemedicine market is projected to grow from $146.9 billion in 2025 to $251.5 billion by 2030 (11.3% CAGR), driven by virtual consultations, chronic disease management, and IoT integration.

Notable Quotes

• "Unidoc is well positioned for strong forward momentum, with the revocation of the CTO and resumption of trading expected shortly after the filing of its financial statements."
• "The company remains fully committed to strengthening its internal procedures to ensure timely and accurate filings in the future."